JPT Peptide Technologies

As part of the deal, the companies will develop peptide-based applications on JPT's high-throughput proteomics screening platform. 

NEW YORK (GenomeWeb News) – JPT Peptide Technologies and The Institute for Medical Immunology at the Charite in Berlin announced on Wednesday an agreement to develop serological peptide biomarkers for the differential diagnosis of chronic fatigue syndrome.

Austrian tools provider Tecan and Berlin-based JPT Peptide Technologies this week announced that they will promote each other's products.

NEW YORK (GenomeWeb News) – Tecan and JPT Peptide Technologies today announced a deal to co-promote JPT's catalog peptide arrays and profiling capabilities.

Arrayjet recently installed a customized version of its Ultra Marathon microarrayer instrument at JPT Technologies.

The Dutch array vendor is working closely with partners in the pharmaceutical industry and academia to optimize internally developed kinase-screening assays for use in drug discovery and as companion diagnostics.

Kinexus President Steven Pelech told BioArray News recently that the new kinase-inhibitor screening service will complement the firm's menu of Kinex antibody and reverse lysate microarrays.

The $6.8 million deal will provide TheraCode with peptide-based services as well as high-content peptide arrays, peptide tools, and peptide libraries.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.